CONCORD BIOTECH LTD.

NSE : CONCORDBIOBSE : 543960ISIN CODE : INE338H01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE1527.45-34.2 (-2.19 %)
PREV CLOSE ( ) 1561.65
OPEN PRICE ( ) 1520.00
BID PRICE (QTY) 1527.00 (5)
OFFER PRICE (QTY) 1540.00 (5)
VOLUME 13828
TODAY'S LOW / HIGH ( )1485.00 1541.90
52 WK LOW / HIGH ( )900 1660
NSE1531.00-29 (-1.86 %)
PREV CLOSE( ) 1560.00
OPEN PRICE ( ) 1540.00
BID PRICE (QTY) 1531.00 (15)
OFFER PRICE (QTY) 1532.40 (2)
VOLUME 127207
TODAY'S LOW / HIGH( ) 1487.05 1544.60
52 WK LOW / HIGH ( )900.05 1660
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1984
Management Info
Sudhir Vaid - Chairman Sudhir Vaid - Managing Director
Registered Office

Address 1482-86 ,Trasad Road,Dholka,
Ahmedabad,
Gujarat-382225

Phone 079-68138700

Email complianceofficer@concordbiotech.com

Website www.concordbiotech.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
06Mar Concord Biotech informs about updates
In compliance with Regulation 30 of SEBI (Listing Obligations and Disclo..
23Feb Concord Biotech gets GMP for unit II o
Ministry of Health Pharmacy and Poisons Board, Republic of Kenya has com..
23Feb Concord Biotech gains on getting GMP f
Concord Biotech is currently trading at Rs. 1463.65, up by 23.40 points..
09Feb Concord Biotech informs about investor
Pursuant to Regulation 30 of Schedule III Part A of SEBI (Listing Obliga..
30Jan Concord Biotech informs about board me
Concord Biotech has informed that the meeting of the Board of Directors..
Financials
Rs. in Millions
QTR Dec 23 ANNUAL
Net Profit745.54
Gross Profit 1000.85
Operating Profit 1141.17
Net Sales
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 7127.00 (7.00%)
M.Cap (Rs. in Cr)9096.39
Bharat Parenterals (BSE)
 1390.00 (2.45%)
M.Cap (Rs. in Cr)768.20
Sanofi India (BSE)
 8512.00 (0.25%)
M.Cap (Rs. in Cr)19609.54
Glaxosmithkline Phar (BSE)
 1904.90 (1.11%)
M.Cap (Rs. in Cr)32218.49
SMS Lifesciences (BSE)
 685.25 (2.58%)
M.Cap (Rs. in Cr)210.87
Shareholding Pattern
PROMOTERS 44.08%
NON-INSTITUTION 41.03%
MUTUAL FUNDS/UTI 5.15%
FI/BANKS/INSURANCE 2.88%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.